The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis

The Clinical Utility of QuantiFERON in the Diagnosis of Active Tuberculosis Among Young Adults

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00982969

Enrollment

200

Registered

2009-09-23

Start date

2008-06-30

Completion date

2010-04-30

Last updated

2010-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Keywords

tuberculosis, pneumonia, QuantiFERON-TB Gold in-tube, Tuberculin skin test

Brief summary

The investigators will evaluate the usefulness of QuantiFERON-TB Gold in-tube (QFT) in the diagnosis of active tuberculosis in young adults group, highly clinically suspected tuberculosis.

Detailed description

Investigators will enroll prospectively all clinically and radiologically suspected tuberculosis patients from 20 to 29 years old who visited the Armed Forces Capital Hospital. Investigators will perform QFT and tuberculin skin test. Diagnosis of tuberculosis will be made by World Health Organization guideline and the physician will not know the QuantiFERON-TB Gold in-tube results before the diagnosis and anti-tuberculosis medication. Investigators will evaluate the sensitivity and specificity of QuantiFERON-TB Gold in-tube in the diagnosis of active tuberculosis among young adults.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

MALE

Healthy volunteers

Yes

Inclusion criteria

* All clinically and radiologically suspected TB patients from 20 to 29 years old who visited the Armed Forces Capital Hospital

Exclusion criteria

* Soldiers who do not agree with study protocol

Countries

South Korea

Outcome results